ABEONA THERAPEUTICS INC. Uncategorized Contracts & Agreements

47 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated February 28, 2022, between the Company and Joseph Vazzano
ABEONA THERAPEUTICS INC.
Biotechnology
2022
Letter Agreement, dated September 16, 2021, between the Company and Brendan OMalley
ABEONA THERAPEUTICS INC.
Biotechnology
2022
Letter Agreement, dated October 6, 2021, between the Company and Vishwas Seshadri
ABEONA THERAPEUTICS INC.
Biotechnology
2022
Amendment No. 1 to Open Market Sale Agreement, dated November 19, 2021, amending the Open Market Sale Agreement, by and between the Company and Jefferies LLC, dated August 17, 2018
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2021
Letter Agreement, dated August 10, 2021, between the Company and Edward Carr
ABEONA THERAPEUTICS INC.
Biotechnology
2021
Letter Agreement, dated March 19, 2021, between the Company and Michael Amoroso
ABEONA THERAPEUTICS INC.
Biotechnology
2021
Amended and Restated Letter Agreement, dated January 27, 2021, between the Company and Michael Amoroso
ABEONA THERAPEUTICS INC.
Biotechnology
2021
Letter Agreement, dated October 26, 2020, between Abeona Therapeutics Inc. and Michael Amoroso
ABEONA THERAPEUTICS INC.
Biotechnology
2020
Amendment No. 3, dated April 14, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
ABEONA THERAPEUTICS INC.
Biotechnology
2020
Offer Letter between Abeona Therapeutics Inc. and Edward Carr, dated June 18, 2020
ABEONA THERAPEUTICS INC.
Biotechnology
2020
Amendment No. 2, dated March 31, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
ABEONA THERAPEUTICS INC.
Biotechnology
2020
Letter Agreement, dated March 13, 2020, between the Company and Christine Berni Silverstein
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2020
Amendment No. 1, dated March 6, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
ABEONA THERAPEUTICS INC.
Biotechnology
2020
Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2020
Offer Letter, dated April 15, 2020, between Abeona Therapeutics Inc. and Brian J.G. Pereira, M.D
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2020
Letter Agreement regarding Certain Purchaser Rights, dated December 20, 2019, among the Company, Biomedical Value Fund, L.P., Biomedical Offshore Value Fund, Ltd., and GEF-SMA, L.P
ABEONA THERAPEUTICS INC.
Biotechnology
2019
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Edward Carr, dated November 9, 2018
ABEONA THERAPEUTICS INC.
Biotechnology
2019
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Christine Berni Silverstein, dated January 8, 2019
ABEONA THERAPEUTICS INC.
Biotechnology
2019
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Joo Siffert, M.D., dated February 11, 2019
ABEONA THERAPEUTICS INC.
Biotechnology
2019
Offer Letter, dated February 11, 2019, by and between Abeona Therapeutics Inc. and Joo Siffert, M.D
ABEONA THERAPEUTICS INC.
Biotechnology
2019
Offer Letter, dated January 8, 2019, by and between Abeona Therapeutics Inc. and Christine Berni Silverstein
ABEONA THERAPEUTICS INC.
Biotechnology
2019
Letter Agreement between Abeona Therapeutics, Inc. and Joo Siffert, M.D., dated November 29, 2018
ABEONA THERAPEUTICS INC.
Biotechnology
2018
Letter Agreement between Abeona Therapeutics, Inc. and Joo Siffert, M.D., dated September 28, 2018
ABEONA THERAPEUTICS INC.
Biotechnology
2018
Offer Letter, effective October 19, 2018, by and between Abeona Therapeutics Inc. and Edward Carr
ABEONA THERAPEUTICS INC.
Biotechnology
2018
Letter of Agreement dated October 5, 2018 by and between the Company and Stephen B. Thompson
ABEONA THERAPEUTICS INC.
Biotechnology
2018
Open Market Sale Agreement, dated August 17, 2018, by and between the Company
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2018
SECURITIESPURCHASE AGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2015
ACCESS Pharmaceuticals, Inc. 1325 Avenue of the Americas, 27th Floor New York, New York10019
ABEONA THERAPEUTICS INC.
Biotechnology
2014
ACCESS Pharmaceuticals, Inc. 1325 Avenue of the Americas, 27th Floor New York, New York10019
ABEONA THERAPEUTICS INC.
Biotechnology
2014
ACCESS NEWS
ABEONA THERAPEUTICS INC.
Biotechnology
2012
ACCESS PHARMACEUTICALS ANNOUNCES PRIVATE PLACEMENT OF $5.2 MILLION
ABEONA THERAPEUTICS INC.
Biotechnology
2011
HUDSON SECURITIES, INC. LETTERHEAD December ___, 2010
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2010
HUDSON SECURITIES, INC. LETTERHEAD November ___, 2010
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2010
AMENDMENTTO RIGHTS AGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
DE
2010
EMPLOYMENTAGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2010
SECURITIESPURCHASE AGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2010
SECURITIESPURCHASE AGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
NY
2010
AMENDMENT TO EMPLOYMENTAGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
2008
_____________________________________________________________________________
ABEONA THERAPEUTICS INC.
Biotechnology
2008
DIRECTOR DESIGNATION AGREEMENT
ABEONA THERAPEUTICS INC.
Biotechnology
2008